For information regarding daily email summary, refer to the following
How it works
To help keep you up-to-date with all your cases we send out daily summaries by email.
All of your typical notifications are consolidated into one daily summary, instead of being spread out across multiple emails. So you'll get just one email every morning, summarizing all the cases you need to think about that day.
If an issue still needs attention the next day, you'll keep seeing it in summary emails until the issue is resolved. Naturally, if there's nothing going on with any of your cases, you won't get an email at all.
Each item in the email summary links directly to the page on dr.clearcorrect.com where you can resolve the issue.
Daily summary categories
Here are some of the categories you might see in your summary:
Under Treatment setup ready, you'll find treatment setups that are waiting for your approval. If a case somehow gets lost in the shuffle, you might discover it lurking here.
Items are sorted oldest to newest. A star (★) in the left column indicates a recent addition.
Waiting for records includes two types of issues:
- If we haven't received all of the required records for a case yet, the notification will have a yellow background.
- If we had to reject records due to quality issues, the notification will have a red background.
Either way, the outcome is the same—the case won't move forward until we receive all of the required records.
Shipments lists phases that have been assigned a tracking number, but haven't arrived at your office yet. Clicking one of these rows takes you to the latest tracking information.
How to adjust daily summary email settings
Everyone is assigned to receive daily summaries by default, but if you liked the old way better, visit the Email Notifications tab under My account. There, you can opt to receive instant notifications instead of—or in addition to—daily summaries. If you really hate email, you can uncheck both boxes to receive the bare minimum: one weekly summary, sent each Monday morning.
Comments
0 comments
Please sign in to leave a comment.